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Introduction: Leishmania parasites are the causative agents of leishmaniasis, group of 
vector-borne parasitic diseases endemic worldwide. Once inoculated into the organism, Leishmania 
parasites are rapidly uptaken by macrophages. Macrophages are primary resident cells for their 
proliferation: they can either phagocyte or allow parasite growth. That is why proper activation of 
macrophages is crucial in disease fate. Macrophage activation is divided into two classes: classical 
(M1) and alternative (M2) that induce parasite killing and its survival, respectively. Classical 
activation is mediated by pro-inflammatory cytokines which cause macrophages to produce toxic 
molecules to kill intracellular parasites. In contrast, alternative activation is induced by anti-
inflammatory cytokines that lead to parasite survival in infected cells. Thalidomide is reported to 
stimulate immune response and enhance cellular phagocytotic activity by selectively inhibiting M2 
pathway. Here, thalidomide was examined as potential drug to have suppressive effect on 
intracellular replication of L.major within infected macrophages in-vitro. 
Methods: To observe macrophage activation, Raw264.7 cells were cultured. After 24hr 
incubation of cells in 370C, 5% CO2 incubator, thalidomide treatment of different concentration was 
done. Supernatant and pellet were collected for ELISA, RT-PCR, qPCR and WB tests. To observe 
pathogen survival, Raw 264.7 cells were cultured in chamber slides and infected with L. major at 
1:10 ratio. After 24hr incubation, thalidomide treatment was done. Giemsa staining was applied to 
slides and intracellular amastigote forms of L.major were counted. 
Results: In this study thalidomide's effect on proper macrophage activation and parasite 
survival was analyzed. It was found that thalidomide can a) up-regulate pro-inflammatory M1 
macrophages (IFN-ү, TNF-a, iNOS); b) down-regulate anti-inflammatory M2 macrophages (IL-10 
and Arg-1); c) decrease intracellular amastigotes of L. major. Thalidomide shows inhibitory effect 
on alternative activation of macrophages and induces M1 polarization of macrophages, thus making 
them resistant to L. major infection. 
Conclusion: Results highlight thalidomide's potential contribution to a new drug 
development towards leishmaniasis in the future. 
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